WithdrawnNot Applicable

CryoSpray Ablation(tm)Thoracic Patient Registry

Stopped: Business Reasons

0Started 2009-04

Plain-language summary

The purpose of this study is to create a patient registry to collect and analyze information on subjects treated with the CryoSpray Ablation™ System post-510K approval.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: Patients who are being treated with the CryoSpray Ablation™ System for lung and for thoracic diseases. Exclusion Criteria: * Subjects with thoracic or airway obstructions and diseases who were not treated with the CryoSpray Ablation™ System. * Subjects under the age of 18 years. * Subjects unable to provide consent.

What they're measuring

Primary objectives of the study are to enable analysis of patient outcomes 2 years following final treatment and estimate the effectiveness of the device in eradicating, decreasing and downgrading of the diseases.

Timeframe: 2 years post-treatment

Trial details

NCT IDNCT00785239

SponsorCSA Medical, Inc.

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2009-04

View on ClinicalTrials.gov More Lung Cancer trials